High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2018-12-01
|
| Series: | ACS Central Science |
| Online Access: | https://doi.org/10.1021/acscentsci.8b00746 |
| _version_ | 1818436193236287488 |
|---|---|
| author | Kin Man Au Rod Balhorn Monique C. Balhorn Steven I. Park Andrew Z. Wang |
| author_facet | Kin Man Au Rod Balhorn Monique C. Balhorn Steven I. Park Andrew Z. Wang |
| author_sort | Kin Man Au |
| collection | DOAJ |
| first_indexed | 2024-12-14T17:04:53Z |
| format | Article |
| id | doaj.art-51df0b18cdec4cb3a0d228c75679a275 |
| institution | Directory Open Access Journal |
| issn | 2374-7951 |
| language | English |
| last_indexed | 2024-12-14T17:04:53Z |
| publishDate | 2018-12-01 |
| publisher | American Chemical Society |
| record_format | Article |
| series | ACS Central Science |
| spelling | doaj.art-51df0b18cdec4cb3a0d228c75679a2752022-12-21T22:53:45ZengAmerican Chemical SocietyACS Central Science2374-79512018-12-015112214410.1021/acscentsci.8b00746High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated NanoparticlesKin Man Au0Rod Balhorn1Monique C. Balhorn2Steven I. Park3Andrew Z. Wang4†Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United StatesSHAL Technologies, Inc., Livermore, California, United StatesSHAL Technologies, Inc., Livermore, California, United StatesLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States†Laboratory of Nano- and Translational Medicine, Carolina Center for Cancer Nanotechnology Excellence, Carolina Institute of Nanomedicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United Stateshttps://doi.org/10.1021/acscentsci.8b00746 |
| spellingShingle | Kin Man Au Rod Balhorn Monique C. Balhorn Steven I. Park Andrew Z. Wang High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles ACS Central Science |
| title | High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles |
| title_full | High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles |
| title_fullStr | High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles |
| title_full_unstemmed | High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles |
| title_short | High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles |
| title_sort | high performance concurrent chemo immuno radiotherapy for the treatment of hematologic cancer through selective high affinity ligand antibody mimic functionalized doxorubicin encapsulated nanoparticles |
| url | https://doi.org/10.1021/acscentsci.8b00746 |
| work_keys_str_mv | AT kinmanau highperformanceconcurrentchemoimmunoradiotherapyforthetreatmentofhematologiccancerthroughselectivehighaffinityligandantibodymimicfunctionalizeddoxorubicinencapsulatednanoparticles AT rodbalhorn highperformanceconcurrentchemoimmunoradiotherapyforthetreatmentofhematologiccancerthroughselectivehighaffinityligandantibodymimicfunctionalizeddoxorubicinencapsulatednanoparticles AT moniquecbalhorn highperformanceconcurrentchemoimmunoradiotherapyforthetreatmentofhematologiccancerthroughselectivehighaffinityligandantibodymimicfunctionalizeddoxorubicinencapsulatednanoparticles AT stevenipark highperformanceconcurrentchemoimmunoradiotherapyforthetreatmentofhematologiccancerthroughselectivehighaffinityligandantibodymimicfunctionalizeddoxorubicinencapsulatednanoparticles AT andrewzwang highperformanceconcurrentchemoimmunoradiotherapyforthetreatmentofhematologiccancerthroughselectivehighaffinityligandantibodymimicfunctionalizeddoxorubicinencapsulatednanoparticles |